|
CAMKK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90815999999705E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.121740E-03 |
| Normal-vs-Stage2 |
3.419600E-02 |
| Normal-vs-Stage3 |
3.0487000000079E-06 |
| Normal-vs-Stage4 |
1.70300000001955E-06 |
| Stage1-vs-Stage2 |
3.563400E-01 |
| Stage1-vs-Stage3 |
3.655600E-02 |
| Stage1-vs-Stage4 |
1.933790E-02 |
| Stage2-vs-Stage3 |
2.400100E-02 |
| Stage2-vs-Stage4 |
1.479920E-02 |
| Stage3-vs-Stage4 |
6.958600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.19600000000476E-05 |
| Normal-vs-AfricanAmerican |
2.847500E-04 |
| Normal-vs-Asian |
1.175010E-04 |
| Caucasian-vs-AfricanAmerican |
9.419400E-01 |
| Caucasian-vs-Asian |
7.456400E-01 |
| AfricanAmerican-vs-Asian |
8.641800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.41190000000291E-05 |
| Normal-vs-Female |
5.5532999999941E-05 |
| Male-vs-Female |
9.921800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.769820E-04 |
| Normal-vs-Age(41-60Yrs) |
1.778930E-03 |
| Normal-vs-Age(61-80Yrs) |
1.645260E-04 |
| Normal-vs-Age(81-100Yrs) |
9.931700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.948800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.312800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.936400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.006400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.952400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.969800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.593440E-01 |
| Classical-VS-Follicular |
2.521000E-01 |
| Classical-VS-Other |
4.508200E-01 |
| Classical-VS-Normal |
9.75380000000081E-05 |
| Tall-VS-Follicular |
8.835900E-02 |
| Tall-VS-Other |
8.774400E-01 |
| Tall-VS-Normal |
2.03559999999436E-05 |
| Follicular-VS-Other |
2.871200E-01 |
| Follicular-VS-Normal |
7.850400E-02 |
| Other-VS-Normal |
4.430000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.581200E-03 |
| Normal-vs-N1 |
1.20369999967451E-07 |
| N0-vs-N1 |
2.423500E-03 |
|
|
